click below
click below
Normal Size Small Size show me how
GI Disorders
BDK
| Generic Name | Brand Name | Pharmacologic Category | Classification | Common Indications | Key Side Effects | US Boxed Warnings & Contraindi | Drug Interactions |
|---|---|---|---|---|---|---|---|
| Calcium carbonate | Tums, Os-Cal | Antacid | OTC | Mild/moderate episodic heartburn; bone health supplement | Constipation, bloating, belching/flatulence | C/I: Hypercalcemia, severe renal dysfunction | Medications should be separated from antacids by 2-4 hours |
| Aluminum hydroxide/ magnesium hydroxide/ simethicone | Maalox Advanced Maximum Strength Liquid | Antacid | OTC | Mild/moderate episodic heartburn | Constipation/diarrhea, hypophosphatemia, renal failure, bone demineralization | C/I: Severe renal dysfunction | Medications should be separated from antacids by 2-4 hours, aluminum combined with magnesium to balance bowel effects |
| Aluminum hydroxide/ magnesium hydroxide/ simethicone | Mylanta Maximum Strength Liquid | Antacid | OTC | Mild/moderate episodic heartburn | Constipation/diarrhea, hypophosphatemia, renal failure, bone demineralization | C/I: Severe renal dysfunction | Medications should be separated from antacids by 2-4 hours, aluminum combined with magnesium to balance bowel effects |
| Magnesium hydroxide | Milk of Magnesia | Antacid | OTC | Mild/moderate episodic heartburn | Diarrhea | C/I: Severe renal dysfunction | Medications should be separated from antacids by 2-4 hours, aluminum combined with magnesium to balance bowel effects |
| Sodium bicarbonate/ anhydrous citric acid | Alka-Seltzer Heartburn | Antacid | OTC | Mild/moderate episodic heartburn | Belching/flatulence; may worsen edema in HF, renal failure, pregnancy, or cirrhosis; milk-alkali syndrome | C/I: Severe renal dysfunction | Medications should be separated from antacids by 2-4 hours |
| Sodium bicarbonate/ anhydrous citric acid/ aspirin | Alka-Seltzer Original | Antacid | OTC | Mild/moderate episodic heartburn | Belching/flatulence; may worsen edema in HF, renal failure, pregnancy, or cirrhosis; milk-alkali syndrome | C/I: Salicylates, high bleeding risk; children <18 y/o | Medications should be separated from antacids by 2-4 hours |
| Aluminum hydroxide/ magnesium carbonate | Gaviscon Extra Strength Liquid | Antacid | OTC | Mild/moderate episodic heartburn | Constipation/diarrhea, hypophosphatemia, renal failure, bone demineralization | C/I: Severe renal dysfunction | Medications should be separated from antacids by 2-4 hours, aluminum combined with magnesium to balance bowel effects |
| Famotidine | Pepcid, Pepcid AC, Zantac 360 | H2 receptor antagonist | Mild to moderate episodic heartburn, GERD | hallucinations (elderly); ↓ libido, impotence, gynecomastia, galactorrhea, breast soreness | QID dosing, dose adjustments required in renal dysfunction, tachyphylaxis after 2 weeks scheduled use | ||
| Famotidine/calcium carbonate/magnesium hydroxide | Pepcid Complete | H2 receptor antagonist | Post-prandial heartburn if not premedicated with an H2RA or antacid | hallucinations (elderly); ↓ libido, impotence, gynecomastia, galactorrhea, breast soreness | BID max, dose adjustments required in renal dysfunction, tachyphylaxis after 2 weeks scheduled use | ||
| Cimetidine | Tagamet | H2 receptor antagonist | Mild to moderate episodic heartburn, GERD | hallucinations (elderly); ↓ libido, impotence, gynecomastia, galactorrhea, breast soreness | BID max, dose adjustments required in renal dysfunction, tachyphylaxis after 2 weeks scheduled use | ||
| Nizatidine | Axid | H2 receptor antagonist | Mild to moderate episodic heartburn, GERD | hallucinations (elderly); ↓ libido, impotence, gynecomastia, galactorrhea, breast soreness | BID max, dose adjustments required in renal dysfunction, tachyphylaxis after 2 weeks scheduled use | ||
| Ranitidine | Zantac | H2 receptor antagonist | Mild to moderate episodic heartburn, GERD | hallucinations (elderly); ↓ libido, impotence, gynecomastia, galactorrhea, breast soreness | BID max, dose adjustments required in renal dysfunction, tachyphylaxis after 2 weeks scheduled use | ||
| Esomeprazole | Nexium | Proton pump inhibitor | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | IV available, daIily - BID, do not chew/crush/take with food | ||
| Omeprazole | Prilosec | Proton pump inhibitor | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | daily – BID, do not chew/crush/take with food | ||
| Omeprazole/sodium bicarbonate | Zegerid | Proton pump inhibitor + antacid | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | daily – BID, do not chew/crush/take with food | ||
| Lansoprazole | Prevacid | Proton pump inhibitor | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | daily – BID, do not chew/crush/take with food | ||
| Dexlansoprazole | Dexilant | Proton pump inhibitor (dual delayed-release) | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | daily – BID, do not chew/crush, taken without regard to meals | ||
| Pantoprazole | Protonix | Proton pump inhibitor | heartburn occurring 2 or more days per week or diagnosed GERD | thrombophlebitis, SJS/TEN, HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous/SLE; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | IV available, daily - BID, do not chew/crush, EC taken without regard to meals | ||
| Rabeprazole | AcipHex | Proton pump inhibitor | heartburn occurring 2 or more days per week or diagnosed GERD | HA, abdominal pain, nausea, diarrhea, constipation, flatulence, rebound acid hypersecretion, AIN, cutaneous and systemic lupus erythematosus; traveler’s diarrhea, CDI, SBP, Mg, B12, Ca, Fe, reduced BMD/osteoporosis, CV events, pneumonia, CKD, dementia | daily – BID, do not chew/crush, EC taken without regard to meals | ||
| Sucralfate | Carafate | Gastrointestinal protectant (coating agent) | PUD | Constipation, salicylate toxicity with high dose/prolonged use; hypophosphatemia; bezoar formation | C/I: Renal failure (aluminum accumulation), children, pregnancy | QID dosing; give other meds ≥2 h before or 4 h after; | |
| Metoclopramide | Reglan | Prokinetic; D2 antagonist | simple NV, especially associated with gastroparesis, refractory pregnancy-associated NV, PONV | extrapyramidal symptoms, CNS depression, diarrhea, QT prolongation, galactorrhea, gynecomastia | BBW: Tardive dyskinesia risk | Reduce dose in renal impairment | |
| Bismuth subsalicylate | Pepto-Bismol | topical antibacterial; gastroprotective | H. pylori (part of BQT), dyspepsia | Black stool/tongue; bleeding risk | C/I: Salicylate allergy; children/teens with viral illness (Reye’s risk) | If salicylate allergy, use bismuth subcitrate | |
| Bismuth subcitrate | Pylera (when in combo) | topical antibacterial; gastroprotective | H. pylori (BQT alternative) | Black stool/tongue; bleeding risk | C/I: Caution in renal failure/elderly | Use when salicylate allergy present | |
| Amoxicillin | Aminopenicillin antibiotic | Diarrhea, stomach upset, hypersensitivity reactions | C/I: Penicillin allergy | ||||
| Metronidazole | Flagyl | Antibiotic | anaerobes; CDI | Metallic taste, nausea; disulfiram-like reaction with alcohol | C/I: Alcohol use | No alcohol during therapy | |
| Tetracycline | Tetracycline antibiotic | Photosensitivity; esophagitis | C/I: Pregnancy; children <8 years | Take with plenty of fluids to reduce esophagitis | |||
| Rifabutin | Rifamycin antibiotic | Rash, leukopenia; orange discoloration; GI upset; diarrhea | High pill burden; now first-line in some cases | ||||
| Clarithromycin | Biaxin | Macrolide antibiotic | Metallic taste, diarrhea; QT prolongation | Avoid empiric use due to resistance unless susceptibilities known | |||
| Vonoprazan | Voquezna | Potassium-competitive acid blocker (PCAB) | GERD; H. pylori (dual/triple) | ↑ fracture risk (high dose or >1 yr) | can take with or without food | ||
| Levofloxacin | Levaquin | Fluoroquinolone antibiotic | QTc prolongation, tendon rupture, increased LFTs, photosensitivity | BBW: tendon rupture, peripheral neuropathy, CNS effects, exacerbation of myasthenia gravis | |||
| Misoprostol | Cytotec | Prostaglandin | Nausea, diarrhea, abdominal cramping, flatulence, hypophosphatemia | BBW: abortifacient properties, uterine rupture, do not used for reducing risk of NSAID-induced ulcers in women of childbearing potential unless patient is high risk; requires pregnancy testing and effective contraception | QID dosing | ||
| Ondansetron | Zofran, Zuplenz | 5-HT3 receptor antagonist | simple nausea/vomiting, pregnancy associated NV, CINV (acute phase), PONV | Headache, constipation; QTc prolongation, serotonin syndrome | C/I with apomorphine (severe hypotension, LOC) | IV doses should not exceed 16 mg due to QTc prolongation | |
| Granisetron (patch) | Sancuso (patch) | 5-HT3 receptor antagonist | simple nausea/vomiting, pregnancy associated NV, CINV (acute phase), PONV | Headache, constipation; QTc prolongation, serotonin syndrome | C/I with apomorphine (severe hypotension, LOC) | applied 24-48 hours before chemotherapy, may leave in place up to 7 days | |
| Granisetron (SubQ) | Sustol (SC ER) | 5-HT3 receptor antagonist | simple nausea/vomiting, pregnancy associated NV, CINV (acute phase), PONV | Headache, constipation; QTc prolongation, serotonin syndrome | C/I with apomorphine (severe hypotension, LOC) | extended release, effective for delayed CINV | |
| Palonosetron | Aloxi | 5-HT3 receptor antagonist | simple nausea/vomiting, pregnancy associated NV, CINV (acute phase), PONV | Headache, constipation; QTc prolongation, serotonin syndrome | C/I with apomorphine (severe hypotension, LOC) | PO formulation only available in combination with netupitant | |
| Dolasetron | Anzemet | 5-HT3 receptor antagonist | simple nausea/vomiting, pregnancy associated NV, CINV (acute phase), PONV | Headache, constipation; QTc prolongation, serotonin syndrome | C/I with apomorphine (severe hypotension, LOC) | PO only | |
| Prochlorperazine | Compazine | Dopamine antagonist (Phenothiazine) | Simple NV, PONV, breakthrough CINV | prolonged QTc interval, anticholinergic effects, EPS, neuroleptic malignant syndrome | Boxed: increased mortality in elderly patients with dementia-related psychosis | Oral, IM, IV, rectal | |
| Chlorpromazine | Thorazine | Dopamine antagonist (Phenothiazine) | Simple NV, PONV, breakthrough CINV | prolonged QTc interval, anticholinergic effects, EPS, neuroleptic malignant syndrome | Boxed: increased mortality in elderly patients with dementia-related psychosis | Oral, IM, IV | |
| Promethazine | Phenergan, Promethegan | Dopamine antagonist (Phenothiazine) | Simple NV, PONV, breakthrough CINV | prolonged QTc interval, anticholinergic effects, EPS, neuroleptic malignant syndrome | BBW: Do not use in <2 years (risk of respiratory depression); severe tissue injury w/injectable formulation: do not give intra-arterial or SQ, IV route can cause tissue necrosis if extravasation occurs, deep IM preferred if oral unavailable | Deep IM preferred if oral unavailable; avoid IV where possible | |
| Droperidol | Inapsine | Dopamine antagonist (Butyrophenone) | Rescue antiemetic for PONV | prolonged QTc interval, anticholinergic effects, EPS, neuroleptic malignant syndrome | BBW: QTc prolongation—12-lead EKG prior and monitor 2–3 h post-dose | ||
| Haloperidol | Haldol | Dopamine antagonist (Butyrophenone) | Breakthrough CINV; palliative care | prolonged QTc interval, anticholinergic effects, EPS, neuroleptic malignant syndrome | Boxed: ↑ mortality in dementia-related psychosis (antipsychotics) | ||
| Olanzapine | Zyprexa | Dopamine antagonist; antipsychotic | CINV in combination with aprepitant/fosaprepitant & 5-HT3-RA, adjunct PONV | sedation, orthostatic hypotension, ↑QTc, neuroleptic malignant syndrome (rare) | Boxed: ↑ mortality in dementia-related psychosis | ||
| Aprepitant | Emend | NK1 receptor antagonist | CINV, PONV (off-label) | constipation, headache, QTc prolongation, serotonin syndrome | ↓ dexamethasone dose by ~50%; ↓ hormonal contraceptive exposure during & 28 days after (back-up birth control); redosing on subsequent days for high emetic risk chemotherapy | ||
| Fosaprepitant | Emend (IV) | NK1 receptor antagonist | CINV, PONV (off-label) | constipation, headache, QTc prolongation, serotonin syndrome | ↓ dexamethasone dose by ~50%; ↓ hormonal contraceptive exposure during & 28 days after (back-up birth control); redosing on subsequent days for high emetic risk chemotherapy | ||
| Netupitant/palonosetron | Akynzeo | NK1 antagonist + 5-HT3 antagonist | CINV, PONV (off-label) | constipation, headache, QTc prolongation, serotonin syndrome | Oral combo; IV prodrug available as fosnetupitant/palonosetron | ||
| Dronabinol | Marinol | Cannabinoid (CB1/CB2 agonist) | Rx (C-II solution / C-III capsule) | Breakthrough CINV; appetite stimulation | Cannabinoid-induced hyperemesis syndrome (CHS), somnolence, euphoria, increased appetite | Solution contains 50% alcohol; refrigerate; solution higher bioavailability than capsules | |
| Nabilone | Cesamet | Cannabinoid (CB1 agonist) | Rx (C-II) | Breakthrough CINV; appetite stimulation | Cannabinoid-induced hyperemesis syndrome (CHS), somnolence, euphoria, increased appetite | Use caution with psychiatric history/substance abuse | |
| Scopolamine | Transderm Scop | Antimuscarinic | Rx (patch) | Motion sickness; adjunct for NV/PONV | Anticholinergic AEs (dry mouth, blurred vision, confusion) | Apply 4 h before travel; replace q72h; remove before MRI; behind ear application | |
| Dimenhydrinate | Dramamine | Antihistamine (H1) with antimuscarinic activity | OTC | Motion sickness; NV | Drowsiness, anticholinergic AEs; constipation | caution in angle-closure glaucoma, BPH; avoid in elderly, asthma | Take 30–60 min before travel, continue during travel |
| Diphenhydramine | Benadryl | Antihistamine (H1) | OTC (Rx IV) | Motion sickness; NV | prolong QTc; sedation; anticholinergic AEs | QTc prolonging drugs; caution in angle-closure glaucoma, BPH; avoid in elderly, asthma | Avoid operating machinery; caution in elderly/asthma |
| Meclizine | Antivert, Bonine, Dramamine All Day Less Drowsy | Antihistamine (H1) | OTC | Motion sickness; NV | Drowsiness (less), anticholinergic AEs | caution in angle-closure glaucoma, BPH; avoid in elderly, asthma | Take 1 h before travel then q12–24 h PRN |
| Hydroxyzine | Vistaril, Atarax | Antihistamine (H1) | Rx | NV (limited), anxiety adjunct | prolong QTc; sedation; anticholinergic AEs | QTc prolonging drugs; caution in angle-closure glaucoma, BPH; avoid in elderly, asthma | Avoid in elderly and when operating machinery |
| Doxylamine | — | Antihistamine (H1) | OTC | NV of pregnancy (with or without pyridoxine) | Sedation; anticholinergic AEs | caution in angle-closure glaucoma, BPH; avoid in elderly, asthma | Common combo with pyridoxine |
| Pyridoxine (Vitamin B6) | — | Vitamin | OTC | First-line for nausea of pregnancy | High-dose neuropathy (long-term) | Typical 12.5–25 mg PO TID–QID; combine with doxylamine if needed | |
| Ginger | — | Herbal product | OTC | Pregnancy NV, motion sickness, PONV | Mild GI upset; belching; potential bleeding risk | Doses 250 mg–2 g/day divided; ~1 g/day may be more effective | |
| Clarithromycin | Antibiotic (macrolide) | ||||||
| Metronidazole | Antibiotic |